LEADER 04431oam 2200529 450 001 9910814829503321 005 20170523091546.0 010 $a1-283-94152-X 010 $a0-12-394615-8 035 $a(OCoLC)860497576 035 $a(MiFhGG)GVRL8DJM 035 $a(EXLCZ)992670000000328965 100 $a20120726d2013 uy 0 101 0 $aeng 135 $aurun|---uuuua 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aSpace groups for solid state scientists /$fGerald Burns, A.M. Glazer 205 $a3rd ed. 210 $aAmsterdam ;$aBoston $cElsevier$dc2013 210 1$aWaltham, MA :$cAcademic Press,$d2013. 215 $a1 online resource (xiii, 408 pages) $cillustrations (some color) 225 0 $aGale eBooks 300 $aPrevious ed. by Gerald Burns. 311 $a0-12-394400-7 320 $aIncludes bibliographical references and index. 327 $aFront Cover; Space Groups for Solid State Scientists; Copyright; Contents; Preface; Chapter 1 Point Symmetry Operations; WHAT IS SYMMETRY?; 1.1. SYMMETRY OPERATIONS; 1.2. POINT SYMMETRY OPERATIONS; 1.3. HEXAGONAL COORDINATES; Chapter 2 Crystal Systems; HAU?Y'S LEGACY; 2.1. LATTICE; 2.2. UNIT CELL; 2.3. CRYSTAL STRUCTURE; 2.4. CRYSTAL SYSTEMS; 2.5. SUMMARY; Chapter 3 Bravais Lattices; SYMMETRY AND LATTICES; 3.1. CENTERING OF LATTICES; 3.2. THE 14 BRAVAIS LATTICES; 3.3. PRIMITIVE CELLS OF THE 14 BRAVAIS LATTICES; 3.4. THE WIGNER-SEITZ UNIT CELL; 3.5. TWO-DIMENSIONAL LATTICES 327 $aChapter 4 Crystallographic Point GroupsINTRODUCTION TO GROUPS; 4.1. DEVELOPMENT OF CRYSTALLOGRAPHIC POINT GROUPS; 4.2. THE POINT GROUPS FOR EACH CRYSTAL SYSTEM; 4.3. THE 32 POINT GROUPS FROM HOLOHEDRIES; 4.4. LAUE CLASSES AND GROUPS; 4.5. POINT GROUP NOTATION; Chapter 5 Development of Space Groups; SPACE GROUP OPERATORS; 5.1. THE SYMMORPHIC SPACE GROUPS; 5.2. NON-SYMMORPHIC OPERATIONS; 5.3. POINT GROUP OF A SPACE GROUP; 5.4. SPACE GROUPS; 5.5. DERIVATION OF SPACE GROUPS; 5.6. SPACE GROUP CLASSIFICATIONS; 5.7. TWO-DIMENSIONAL SPACE GROUPS; 5.8. SUBPERIODIC GROUPS; Chapter 6 Reading the Tables 327 $aWHAT DOES THE ITA TELL US?6.1. CRYSTAL STRUCTURE AND SPACE GROUPS; 6.2. 'TYPICAL' PAGES OF THE ITA; 6.3. EXAMPLE PAGES FROM THE ITA; 6.4. SUBGROUPS AND SUPERGROUPS4; 6.5. SPACE GROUP SYMMETRY OPERATIONS; 6.6. HALL SPACE GROUP SYMBOLS; Chapter 7 Space Group Applications; AND NOW ATOMS; 7.1. FACE-CENTERED CUBIC STRUCTURES; 7.2. PRIMITIVE CUBIC STRUCTURES; 7.3. BODY-CENTERED CUBIC STRUCTURES; 7.4. DIAMOND STRUCTURE; 7.5. SPINEL STRUCTURE; 7.6. ZINC SULPHIDE STRUCTURE; 7.7. CHALCOPYRITE; 7.8. SEMICONDUCTOR SUPERLATTICES; 7.9. STRUCTURAL PHASE TRANSITIONS IN CRYSTALS; 7.10. DISPLACIVE SPTS 327 $a8.5. BLACK AND WHITE SPACE GROUPS8.6. MAGNETIC SPACE GROUPS; 8.7. EXAMPLES OF MAGNETIC STRUCTURES; 8.8. REPRESENTATION METHOD; 8.9. OG/BNS MAGNETIC GROUP SYMBOLS; Appendix 1 Matrices Representing the Symmetry Operations; JONES' FAITHFUL REPRESENTATION SYMBOLS; Appendix 2 Crystal Families, Systems, and Bravais Lattices; Appendix 3 The 14 Bravais Lattices; 24 WIGNER-SEITZ CELLS; Appendix 4 The 32 Crystallographic Point Groups; Appendix 5 Diagrams for the 32 Point Groups; STEREOGRAMS; SOME SHAPES ILLUSTRATING THE 32 POINT GROUPS; Appendix 6 Symbols; SYMBOLS OF SYMMETRY PLANES 327 $aSYMBOLS OF SYMMETRY AXES 330 $aThis comprehensively revised - essentially rewritten - new edition of the 1990 edition (described as ""extremely useful"" by MATHEMATICAL REVIEWS and as ""understandable and comprehensive"" by Scitech) guides readers through the dense array of mathematical information in the International Tables Volume A. Thus, most scientists seeking to understand a crystal structure publication can do this from this book without necessarily having to consult the International Tables themselves. This remains the only book aimed at non-crystallographers devoted to teaching them about crystallo 606 $aSolid state physics 606 $aSpace groups 615 0$aSolid state physics. 615 0$aSpace groups. 676 $a530.4/1 676 $a530.4/1 700 $aGlazer$b A. M$g(Anthony Michael)$01676733 702 $aBurns$b Gerald$f1932- 801 0$bMiFhGG 801 1$bMiFhGG 906 $aBOOK 912 $a9910814829503321 996 $aSpace groups for solid state scientists$94043112 997 $aUNINA LEADER 04475nam 2200685 a 450 001 9910960901503321 005 20251017110055.0 010 $a9780309168953 010 $a0309168953 010 $a9780309503747 010 $a0309503744 035 $a(CKB)111069351130742 035 $a(EBL)3375300 035 $a(SSID)ssj0000106797 035 $a(PQKBManifestationID)11138488 035 $a(PQKBTitleCode)TC0000106797 035 $a(PQKBWorkID)10132373 035 $a(PQKB)10978189 035 $a(MiAaPQ)EBC3375300 035 $a(Perlego)4737441 035 $a(DNLM)1173941 035 $a(BIP)116906994 035 $a(BIP)8022501 035 $a(EXLCZ)99111069351130742 100 $a20030217d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 03$aAn assessment of the CDC anthrax vaccine safety and efficacy research program /$fCommittee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Medical Follow-up Agency, Institute of Medicine 205 $a1st ed. 210 $aWashington, D.C. ;$a[Great Britain] $cNational Academy Press$dc2003 215 $a1 online resource (179 p.) 300 $aDescription based upon print version of record. 311 08$a9780309086264 311 08$a0309086264 327 $a""Front Matter""; ""Preface""; ""Reviewers""; ""Contents""; ""Figures, Tables, and Boxes""; ""Abbreviations and Acronyms""; ""Executive Summary""; ""1 Introduction""; ""2 Background""; ""3 The CDC Anthrax Vaccine Research Plan""; ""4 Proposed Studies on the Efficacy of the Anthrax Vaccine""; ""5 Proposed Studies on the Safety of the Anthrax Vaccine""; ""6 Proposed Studies on the Acceptability of the Anthrax Vaccine""; ""7 Summary Assessment of the CDC Anthrax Vaccine Research Plan""; ""Appendix A Biographical Sketches""; ""Appendix B Information-Gathering Meeting Agendas"" 327 $a""Appendix C Anthrax Vaccine Safety & Efficacy Research Plan""""Appendix D Food and Drug Administration Final Rule: New Drug and Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible""; ""Appendix E Department of Defense Memorandum: Reintroduction of the Anthrax Vaccine Immunization Program""; ""Appendix F Institute of Medicine: CDC Anthrax Vaccine Safety & Efficacy Research Program. Interim Report Findings and Recommendations1"" 327 $a""Appendix G Institute of Medicine: The Anthrax Vaccine: Is It Safe? Does It Work? Findings and Recommendations1"" 330 $aIn 1998, the Department of Defense (DoD) began a program of mandatory immunization against anthrax for all military personnel. As the program proceeded, however, some military personnel and their families raised concerns about the safety and efficacy of the anthrax vaccine. Acknowledging both the need to protect military personnel and the concerns about the anthrax vaccine, congress directed the Centers for Disease Control and Prevention (CDC) to carry out a research program on its safety and efficacy. To assist in the development of this program, CDC requested the Institute of Medicine (IOM) to convene a committee to review the completeness and appropriateness of the research program. In An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program , the committee makes an overall assessment of the CDD research plan and reviews the specific studies proposed by CDC in the three areas of efficacy, safety and acceptability. The committee also notes additional research needs that became evident following the bioterrorist events of 2001 and makes recommendations about the leadership of the research program. 606 $aAnthrax$xVaccination 606 $aPublic health 606 $aAnthrax Vaccines$3(DNLM)D022122 606 $aSafety$3(DNLM)D012449 606 $aResearch$3(DNLM)D012106 615 0$aAnthrax$xVaccination. 615 0$aPublic health. 615 2$aAnthrax Vaccines. 615 2$aSafety. 615 2$aResearch. 676 $a615.372 712 02$aInstitute of Medicine (U.S.) Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910960901503321 996 $aAn assessment of the CDC anthrax vaccine safety and efficacy research program$94357625 997 $aUNINA